A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 18, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Nov 2, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the WRB SEC filings page.
W.R. Berkley Corporation (WRB) reported $14.9B in revenue over the twelve months to Sep 30, 2026, up 1.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue is still expanding, but FY2025 growth converted less efficiently into profit and cash while equity strengthened the balance sheet.
In FY2025, revenue grew7.8% but net income rose only1.3% ; top-line growth no longer translated proportionally into earnings. Operating cash flow remained201.3% of net income, down from209.5% in FY2024, so cash conversion remains favorable but is less pronounced.
Equity grew
From FY2023 to FY2025, net income grew
Financial Health Signals
Scored against insurers for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 5 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of W.R. Berkley Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Loss Ratio measures the claims an insurer paid out against the premiums it earned, so a lower ratio leaves more of every premium dollar with the company. W.R. Berkley Corporation scores 58/100 on it among other insurers.
Premium Growth ranks insurers on the yearly rate at which the premiums they write compounded across the last three fiscal years (the last two where the earliest reports none), counted in premiums rather than in total revenue and in the currency each insurer reports in. W.R. Berkley Corporation scores 53/100 on it among other insurers.
W.R. Berkley Corporation funded 22.1% of its assets with shareholders' equity at the end of fiscal year 2025, holding $9.7B of equity against $43.9B of assets. Capital ranks insurers on that cushion, and W.R. Berkley Corporation scores 44/100 among other insurers.
Not available for W.R. Berkley Corporation, so it is left out of the overall score, which averages the 5 of 6 dimensions that can be computed.
Combined Ratio puts claims and running costs together against premiums earned, and a figure under 100% means the underwriting made money before any investment income was counted. W.R. Berkley Corporation scores 74/100 on it among other insurers.
Stability ranks insurers on how far their net income strayed from its own average over the last five fiscal years, measured against the size of that average, and a smaller spread ranks higher. W.R. Berkley Corporation scores 92/100 on it among other insurers.
W.R. Berkley Corporation passes 4 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) does not pass.
Key Financial Metrics
Earnings & Revenue
W.R. Berkley Corporation generated $3.7B in revenue in Q3 2026. This represents a decrease of 0.8% from the same quarter a year earlier. Against the prior quarter it is up 0.6%.
W.R. Berkley Corporation reported $446.0M in net income in Q3 2026. This represents a decrease of 12.7% from the same quarter a year earlier. Against the prior quarter it is down 1.4%.
W.R. Berkley Corporation earned $1.14 per diluted share (EPS) in Q3 2026. This represents a decrease of 10.9% from the same quarter a year earlier. Against the prior quarter it is down 0.9%.
Not reported for Q3 2026.
Cash & Balance Sheet
W.R. Berkley Corporation held $2.1B in cash as of Q3 2026; no long-term debt figure is on record for that period.
W.R. Berkley Corporation paid $0.10 per share in dividends in Q3 2026. This represents an increase of 11.1% from the same quarter a year earlier. Against the prior quarter it is down 83.3%.
Not reported for Q3 2026.
Margins & Returns
W.R. Berkley Corporation's net profit margin was 11.9% in Q3 2026, showing the share of revenue converted to profit. This is down 1.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.2 percentage points.
W.R. Berkley Corporation's quarterly ROE was 4.6% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is down 0.6 percentage points from the same quarter a year earlier. It is unchanged from the prior quarter.
Not reported for Q3 2026.
Not reported for Q3 2026.
Capital Allocation
W.R. Berkley Corporation spent $21.1M on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 14.1% from the same quarter a year earlier. Against the prior quarter it is down 81.0%.
Not reported for Q3 2026.
Not reported for Q3 2026.
WRB Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.7B-0.8% | $3.7B+1.2% | $3.7B+4.0% | $3.7B+1.5% | $3.8B+10.8% | $3.7B+10.8% | $3.5B+8.9% | $3.7B+13.9% |
| Interest Expense | $31.6M-0.5% | $31.7M-0.2% | $31.7M-0.1% | $31.6M-0.4% | $31.8M+0.1% | $31.8M+0.2% | $31.7M0.0% | $31.8M-0.4% |
| Income Tax | $126.0M-7.4% | $122.9M+1.4% | $100.5M-17.1% | $117.2M-23.4% | $136.1M+24.7% | $121.2M+4.6% | $121.3M-8.2% | $153.0M+49.6% |
| Net Income | $446.0M-12.7% | $452.3M+12.7% | $515.2M+23.4% | $449.5M-22.0% | $511.0M+39.8% | $401.3M+7.9% | $417.6M-5.6% | $576.1M+45.0% |
| EPS (Basic) | $1.15-10.9% | $1.16+14.9% | $1.31+24.8% | $1.13-21.5% | $1.29+40.2% | $1.01+8.6% | $1.05-4.5% | $1.44 |
| EPS (Diluted) | $1.14-10.9% | $1.15+15.0% | $1.31+26.0% | $1.13-21.5% | $1.28+40.7% | $1.00+8.7% | $1.04-4.6% | $1.44 |
| Diluted Shares (Avg) | 391M-2.2% | 392M-2.1% | 395M-1.3% | N/A | 400M-0.4% | 400M-0.8% | 400M-1.5% | N/A |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA.
WRB Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $45.7B+4.5% | $45.7B+7.1% | $44.3B+7.2% | $43.9B+8.3% | $43.7B+8.3% | $42.7B+9.6% | $41.3B+9.2% | $40.6B+9.0% |
| Cash & Equivalents | $2.1B-12.1% | $2.6B+31.3% | $2.3B+32.6% | $2.5B+28.6% | $2.4B+52.8% | $2.0B+25.6% | $1.7B+47.1% | $2.0B+44.9% |
| Goodwill | $184.3M0.0% | $184.3M0.0% | $184.3M0.0% | $184.3M0.0% | $184.3M+0.1% | $184.3M+0.1% | $184.3M+5.6% | $184.3M+5.6% |
| Total Liabilities | $36.1B+6.3% | $35.8B+7.4% | $34.6B+6.6% | $34.2B+6.4% | $33.9B+6.2% | $33.4B+7.2% | $32.4B+7.9% | $32.2B+8.2% |
| Total Equity | $9.6B-1.9% | $9.8B+5.8% | $9.7B+9.3% | $9.7B+15.6% | $9.8B+16.3% | $9.3B+19.6% | $8.9B+14.5% | $8.4B+12.6% |
| Retained Earnings | $14.5B+8.7% | $14.1B+9.6% | $13.8B+9.3% | $13.3B+8.8% | $13.3B+11.7% | $12.8B+9.9% | $12.7B+10.5% | $12.3B+11.1% |
Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Current Liabilities, Non-Current Liabilities, Long-Term Debt.
WRB Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $731.3M-35.8% | $800.0M+13.7% | $667.9M-10.2% | $995.1M+22.9% | $1.1B-8.1% | $703.8M-20.1% | $743.8M-0.3% | $810.0M+16.0% |
| Depreciation & Amortization | -$10.7Mn/m | -$22.1Mn/m | -$15.5Mn/m | -$15.3Mn/m | -$9.1Mn/m | -$14.0Mn/m | -$9.8Mn/m | -$13.6Mn/m |
| Stock-Based Compensation | N/A | N/A | $13.2M+6.5% | N/A | N/A | N/A | $12.4M-4.3% | N/A |
| Investing Cash Flow | -$912.4Mn/m | -$361.0Mn/m | -$588.6Mn/m | -$243.1Mn/m | -$627.6Mn/m | -$234.2Mn/m | -$924.4Mn/m | -$87.1Mn/m |
| Financing Cash Flow | -$306.1Mn/m | -$127.7Mn/m | -$339.1Mn/m | -$618.1Mn/m | -$95.3Mn/m | -$231.7Mn/m | -$81.4Mn/m | -$290.5Mn/m |
| Dividends Paid | $259.8M+659.8% | $0-100.0% | $33.7M+11.1% | $411.9M+86.9% | $34.2M-72.8% | $223.8M+42.1% | $30.3M+7.5% | $220.4M-29.9% |
| Share Buybacks | $21.1M-14.1% | $111.5Mn/m | $302.4M+514.7% | $196.4M+191.3% | $24.6M+97.3% | $0-100.0% | $49.2Mn/m | $67.4M-36.8% |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow.
WRB Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Net Margin | 11.9%-1.6pp | 12.2%+1.2pp | 14.0%+2.2pp | 12.1%-3.6pp | 13.6%+2.8pp | 10.9%-0.3pp | 11.8%-1.8pp | 15.7%+3.4pp |
| Return on Equity | 4.6%-0.6pp | 4.6%+0.3pp | 5.3%+0.6pp | 4.6%-2.2pp | 5.2%+0.9pp | 4.3%-0.5pp | 4.7%-1.0pp | 6.9%+1.5pp |
| Return on Assets | 1.0%-0.2pp | 1.0%+0.1pp | 1.2%+0.1pp | 1.0%-0.4pp | 1.2%+0.3pp | 0.9%0.0pp | 1.0%-0.2pp | 1.4%+0.4pp |
| Liabilities-to-Equity | 3.75+0.3x | 3.64+0.1x | 3.55-0.1x | 3.53-0.3x | 3.46-0.3x | 3.59-0.4x | 3.64-0.2x | 3.83-0.2x |
| Asset Turnover | 0.080.0x | 0.080.0x | 0.080.0x | 0.080.0x | 0.090.0x | 0.090.0x | 0.090.0x | 0.090.0x |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, Debt-to-Equity, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| W.R. Berkley Corporation WRB | FY2025 | $14.7B | $1.8B | 12.1% | $28.6B | 64/100 |
| Cincinnati Financial Corp CINF | FY2025 | $12.6B | $2.4B | 18.9% | $29.0B | 61/100 |
| Loews Corporation L | FY2025 | $18.5B | $1.7B | 9.0% | $22.2B | 43/100 |
| Markel Group Inc. MKL | FY2025 | $15.5B | $2.1B | 13.6% | $23.7B | 48/100 |
| American Financial Group, Inc. AFG | FY2025 | $8.2B | $842.0M | 10.3% | $13.1B | 45/100 |
| CNA Financial Corporation CNA | FY2025 | $15.0B | $1.3B | 8.5% | $13.1B | 43/100 |
Where W.R. Berkley Corporation Ranks
Frequently Asked Questions
W.R. Berkley Corporation (WRB) reported $14.7B in total revenue for fiscal year 2025. This represents a 7.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
W.R. Berkley Corporation (WRB) revenue grew by 7.8% year-over-year, from $13.6B to $14.7B in fiscal year 2025.
Yes, W.R. Berkley Corporation (WRB) reported a net income of $1.9B over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net income of $1.8B, with a net profit margin of 12.1%.
W.R. Berkley Corporation (WRB) had a net profit margin of 12.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Yes, W.R. Berkley Corporation (WRB) paid $1.85 per share in dividends during fiscal year 2025.
W.R. Berkley Corporation (WRB) has a return on equity of 18.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
W.R. Berkley Corporation (WRB) generated $3.6B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
W.R. Berkley Corporation (WRB) had $43.9B in total assets as of fiscal year 2025, including both current and long-term assets.
W.R. Berkley Corporation (WRB) had a liabilities-to-equity ratio of 3.53 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.
W.R. Berkley Corporation (WRB) had a return on assets of 4.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
W.R. Berkley Corporation (WRB) trades at 15.3x earnings, its market capitalization divided by $1.9B net income, trailing 12 months to September 30, 2026. The market capitalization is $28.6B as of Nov 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
W.R. Berkley Corporation (WRB) trades at 1.9x sales, its market capitalization divided by $14.9B revenue, trailing 12 months to September 30, 2026. The market capitalization is $28.6B as of Nov 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
W.R. Berkley Corporation (WRB) has a Piotroski F-Score of 4 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
W.R. Berkley Corporation (WRB) scores 64 out of 100 on our Financial Health Score, indicating moderate standing within its insurers peer group. The score is the average of six dimensions (Loss Ratio, Premium Growth, Capital, Investment Yield, Combined Ratio, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For W.R. Berkley Corporation it averages the 5 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.